Sarah Krug asks if it is time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust.
Sarah Krüg
Advertisement
Articles by Sarah Krüg
In 2011, the patient’s clout as a stakeholder was firmly established, as reflected in several industry conferences. What’s next for the patient in 2012?
Advertisement
Latest Updated Articles
Time to Appoint a 'Chief Patient Officer'?Published: February 1st 2012 | Updated:
- The Rising Clout of the Patient
Published: January 9th 2012 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
